CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vilin Bio Med Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vilin Bio Med Ltd
Phone: +91 4079618843p:+91 4079618843 HYDERABAD, 500009  India Ticker: VILINBIOVILINBIO

Business Summary
Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20223/31/2022-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board VeerareddyVallapureddy 55 1/4/2023 1/4/2023
Chief Financial Officer ChillamSrikanth 43 12/17/2022 12/17/2022
Managing Director, Executive Director Viswa P.Sadhanala 58 10/1/2022 12/1/2021
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 13,950,000 (As of 12/31/2022)
Stock Exchange: NSE
Email Address: vbml2005@gmail.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 14, 2024